Ropinirole for restless legs syndrome: A placebo-controlled crossover trial
Neurology Adler et al.
62: 1405
Data supplement
Two tables; one Word document.
Files in this Data Supplement:
E1-E2
-
Table 1: Supplemental Data: Adverse Events. Comparisons of the incidence of adverse events with onset during ropinirole treatment versus the incidence of adverse events with onset during placebo treatment, among 22 patients who each received both treatments in a crossover design study; Table 2: Comparisons of the incidence of adverse events with onset during ropinirole treatment versus the incidence of adverse events with onset during placebo treatment, among 22 patients who each received both treatments in a crossover design study; Word document.
